Helmex

Helmex is an oral, over‑the‑counter anthelmintic medication containing pyrantel embonate as its active ingredient. It is supplied in tablet (or suspension) form (strength not specified) and is marketed in the European Union. Pyrantel embonate works by targeting intestinal nematodes, providing a therapeutic option for common worm infections. The product is intended for use without a prescription in adults and children, following label directions according to the package insert.

Helmex is indicated for the oral treatment of several common intestinal nematode infections.

- Ascariasis (infection with Ascaris lumbricoides, roundworm) - Hookworm infection (Ancylostoma duodenale or Necator americanus) - Enterobiasis (pinworm infection caused by Enterobius vermicularis) - Other susceptible nematodes such as Trichuris trichiura (whipworm) where clinically appropriate - Uncomplicated infections caused by susceptible intestinal nematodes in adults and children

Adverse reactions to Helmex are generally mild, but rare serious events have been reported.

Common: - Nausea or abdominal discomfort - Diarrhea or loose stools - Mild headache - Transient dizziness

Serious: - Allergic reactions such as rash, urticaria, or angioedema - Severe abdominal pain or colitis - Anaphylactic shock (rare)

Before using Helmex, certain precautions should be considered to ensure safe and effective treatment.

- Verify the diagnosis of a nematode infection and appropriate species susceptibility - Use with caution in patients with known hypersensitivity to pyrantel or related compounds - Consult a healthcare professional before treatment in pregnant or breastfeeding individuals, as safety data are limited - Adjust dosing in young children or those with severe hepatic impairment according to label guidance - Avoid use in patients with a history of intestinal obstruction or severe gastrointestinal disease - Keep out of reach of children; accidental ingestion may cause symptoms

Helmex may interact with other medicines or substances; awareness of potential interactions helps minimize risk.

Avoid: - Concomitant use of cholinergic agents that may enhance neuromuscular effects - Strong CYP450 inducers that could reduce pyrantel exposure (though pyrantel is minimally metabolized)

Use with caution: - Antacids or medications that alter gastric pH, which might affect absorption - Other anthelmintics administered simultaneously, as combined effects are not well studied - Herbal supplements containing cholinergic activity (e.g., nicotine) - Warfarin or other anticoagulants, monitoring recommended if co‑administered